Liquidity headlines often reflect structural features of fund vehicles rather than automatic credit impairment.

If regime holds, control of enriched uranium may be ultimate measure of US-Israeli success, insiders say ...

Company plans to initiate a pivotal phase 3 clinical trial of aglatimagene besadenovec (aglatimagene or CAN-2409) in patients with progressive, metastatic, non-squamous, non-small cell lung cancer ...

Sabrina Martucci Johnson, President and CEO of Daré Bioscience, discusses FDA clearance of the IND for DARE-HPV, the planned Phase 2 clinical study, and what the program could mean for women’s health ...

Infrared cameras inform a convolutional neural network that determines the melt-fraction level of phase change materials.

Phase change energy storage technology has great potential for enhancing the efficient conversion and storage of energy. While triply periodic minimal surface (TPMS) structures have shown promise in ...

Scientists from Tokyo Metropolitan University have discovered that a hydrogen-absorbing material shrinks in one direction ...

Scientists used "atomic LEGOs" to build ultrathin nickel films, discovering a specific electronic "dome" where resistance ...

A hydrogen-treated metal alloy shrinks instead of expanding when heated, driven by magnetism, offering customizable materials ...

A team of physicists has experimentally confirmed a long-predicted sequence of exotic magnetic phases in an atomically thin ...

A material that freezes and melts in order to store and use heat as an energy source could see household energy usage become cheaper and cleaner, a project from experts at Loughborough University has ...

Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development programs of novel and potentially disruptive therapeutics ...